20841546

Source:http://linkedlifedata.com/resource/pubmed/id/20841546

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0018801, umls-concept:C0205178, umls-concept:C0699794, umls-concept:C2348867, umls-concept:C2349179
pubmed:issue	5
pubmed:dateCreated	2010-9-15
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101479941
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1941-3297
pubmed:author	pubmed-author:FelkerG MichaelGM, pubmed-author:MaiselAlan SAS
pubmed:issnType	Electronic
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	643-6
pubmed:dateRevised	2011-10-27
pubmed:meshHeading	pubmed-meshheading:20841546-Acute Disease, pubmed-meshheading:20841546-Biological Markers, pubmed-meshheading:20841546-Clinical Trials as Topic, pubmed-meshheading:20841546-Endpoint Determination, pubmed-meshheading:20841546-Heart Failure, pubmed-meshheading:20841546-Humans, pubmed-meshheading:20841546-Research Design
pubmed:year	2010
pubmed:articleTitle	A global rank end point for clinical trials in acute heart failure.
pubmed:affiliation	Duke Clinical Research Institute, Durham, NC 27705, USA. michael.felker@duke.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't